# Sitagliptin in Non-Diabetic Patients Undergoing General Surgery

> **NCT02741687** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 80 (actual)

## Conditions studied

- Hyperglycemia

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Placebo
- **DRUG:** Supplemental insulin (insulin lispro)
- **DRUG:** Supplemental insulin (insulin aspart)
- **DRUG:** Long acting basal insulin (insulin detemir)
- **DRUG:** Long acting basal insulin (insulin glargine)

## Key facts

- **NCT ID:** NCT02741687
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2018-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02741687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02741687, "Sitagliptin in Non-Diabetic Patients Undergoing General Surgery". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02741687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*